Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
10/10/2012 | EP2507229A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
10/10/2012 | EP2507221A1 Ship1 modulators and methods related thereto |
10/10/2012 | EP2507219A2 Synthesis of syrbactin proteasome inhibitors |
10/10/2012 | EP2506873A2 Vaccine against neoplastic or cancerous lesions caused by human papillomavirus (hpv), procedures, uses and methods |
10/10/2012 | EP2506870A1 Prostate cancer dna vaccine |
10/10/2012 | EP2506864A1 Treatment and prevention of cancers associated with intracellular oncoproteins by antibody therapy or vaccination |
10/10/2012 | EP2506855A1 Anticancer compounds and screening method |
10/10/2012 | EP2506853A1 Combination therapy for treating cancer and diagnostic assays for use therein |
10/10/2012 | EP2506852A2 Interferon therapies in combination with blockade of stat3 activation |
10/10/2012 | EP2506840A1 Uses of hypoxia-inducible factor inhibitors |
10/10/2012 | EP2213738B1 siRNA molecules targeting Bcl-2 |
10/10/2012 | CN1880317B Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
10/10/2012 | CN1714861B Thymus penta peptide slow releasing micro ball and its preparing method |
10/10/2012 | CN1694902B Antibody binding with epitope of EphB4 polypeptides and application thereof |
10/10/2012 | CN1678188B Nucleic acid compositions for stimulating immune responses |
10/10/2012 | CN1662251B Adjuvant enhanced immunotherapy |
10/10/2012 | CN1522156B Novel engineered superantigen for human therapy |
10/10/2012 | CN1371416B Human CTLA-4 antibodies and their uses |
10/10/2012 | CN102725311A Methods of treating inflammation |
10/10/2012 | CN102725310A Isoform specific anti-HER4 antibodies |
10/10/2012 | CN102725298A Hydroxy-substituted cold(III) porphyrin complexes as histone deacetylase inhibitors |
10/10/2012 | CN102725296A Thieno[3,2-d]pyrimidine derivatives having inhibitory activity on protein kinases |
10/10/2012 | CN102725294A Crystalline forms of (s)-1-(4-(5-cyclopropyl-1h-pyrazol-3- ylamino)pyrrolo [1,2-f] [1,2,4] triazin-2-yl)-n-(6-fluoropyridin- 3-yl)-2-methylpyrrolidine-2-carboxamide |
10/10/2012 | CN102725292A Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition |
10/10/2012 | CN102725288A Method for manufacturing a 6-substituted-1-methyl-1H-benzimidazole derivative, and manufacturing intermediate from said method |
10/10/2012 | CN102725287A 1,3,4-oxadiazole-2-carboxamide compound |
10/10/2012 | CN102725283A Compounds and compositions as protein kinase inhibitors |
10/10/2012 | CN102725281A Azole derivatives as WTN pathway inhibitors |
10/10/2012 | CN102725264A Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient |
10/10/2012 | CN102725263A Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient |
10/10/2012 | CN102725003A Aldehydes for in vivo imaging of aldh in cancer stem cells |
10/10/2012 | CN102724993A Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof |
10/10/2012 | CN102724985A Use of lipid conjugates in the treatment of diseases associated with vasculature |
10/10/2012 | CN102724981A Method for predicting therapeutic effect of chemotherapy on hepatocellular carcinoma patient |
10/10/2012 | CN102724980A Therapeutic use of protein-polymer conjugates |
10/10/2012 | CN102724966A Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof |
10/10/2012 | CN102719522A Application of acetylcholinesterase gene promoter in screening anti-hepatoma drugs |
10/10/2012 | CN102719521A Application of cystine/glutamic acid reverse transporter xCT inhibitor in treating liver cancer |
10/10/2012 | CN102719470A Cloning, expressing and protein-purifying method for OPN gene |
10/10/2012 | CN102719441A Preparation method of antibody of trichina antigen gene TS498 associated to breast cancer |
10/10/2012 | CN102719437A Application of mediated PLK1 RNAi (polo-like kinase-1 ribonucleic acid interference) of lentivirus vector in treatment of esophageal squamous carcinoma metastasis |
10/10/2012 | CN102719432A Double-stranded asymmetric small nucleic-acid-interference-molecule asiRNA inhibiting tumour apoptosis suppressor specifically and application thereof |
10/10/2012 | CN102719408A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
10/10/2012 | CN102719399A In vitro amplification method of self-specific T cell, prepared T cell system, pharmaceutical use of cell system and component monitoring method of cell system |
10/10/2012 | CN102718881A Efficient purification technology for ganoderma lucidum polysaccharide |
10/10/2012 | CN102718880A Ganoderma lucidum polysaccharide of high molecular weight and detection method thereof |
10/10/2012 | CN102718870A Insulin bio-sensitizer and application thereof |
10/10/2012 | CN102718867A Polypeptide compound for inhibiting angiogenesis and tumor growth |
10/10/2012 | CN102718856A Recombinant chromatin modified albumin 1A, as well as coding gene and application thereof |
10/10/2012 | CN102718847A Small molecular superantigen modified protein, its encoding gene, preparation process and application thereof |
10/10/2012 | CN102718846A Activity-increased SEC 2 mutant protein, coding gene, preparation and application |
10/10/2012 | CN102718844A Antimicrobial peptide AMitP with acid activation property and synthesis and application thereof in preparation of anti-tumor medicaments |
10/10/2012 | CN102718834A Specific inhibitor of human immune system toxic protein granzyme H, its preparation method and application |
10/10/2012 | CN102718824A Fluorine-containing water-soluble platinum complex for cancer treatment and preparation method thereof |
10/10/2012 | CN102718818A Nitrogenous troxerutin derivative, preparation method thereof and application |
10/10/2012 | CN102718809A New diterpene compound in leaves of rubus corchorifolius L.f as well as preparation method and purpose thereof |
10/10/2012 | CN102718795A Dibutyltin coordination compound and preparation method and application thereof |
10/10/2012 | CN102718794A Dihydrazone Schiff base tindiphenyl (IV) coordinate complex and preparation method and application thereof |
10/10/2012 | CN102718793A Phenyltin coordination compound and preparation method and application thereof |
10/10/2012 | CN102718775A Macrocyclic quinazoline derivatives as antiproliferative agents |
10/10/2012 | CN102718772A Preparation and clinic application of hydroxycamptothecin derivative and preparation thereof |
10/10/2012 | CN102718769A Intermediary tetrasubstituted chlorin compound and application thereof in the field of medicines |
10/10/2012 | CN102718763A Semi-synthetic Quiolizidine alkaloid crystals and preparation method thereof |
10/10/2012 | CN102718750A Aminopyridine derivatives containing acridine ring and application thereof |
10/10/2012 | CN102718745A Novel amino pyridine compound, its preparation method, pharmaceutical composition containing compound and application thereof |
10/10/2012 | CN102718730A Methods of synthesis and/or purification of diaminophenothiazinium compounds |
10/10/2012 | CN102718702A Aminopyridine derivatives and application thereof |
10/10/2012 | CN102718658A Isosteviol derivative as well as preparation method and application thereof |
10/10/2012 | CN102718657A Isosteviol compound as well as preparation method and application thereof |
10/10/2012 | CN102716743A Method for preparing aqueous dispersion nano-cuprous oxide/graphene composite powder |
10/10/2012 | CN102716500A Cationic macromolecular proteolipid gene medicine carrier, preparation method and application |
10/10/2012 | CN102716498A Drug liposome capable of efficient and highly specific killing of P53 gene mutation type of breast cancer cells |
10/10/2012 | CN102716497A Alpha1,3 galactosyltransferase-transfected material, its preparation method and application |
10/10/2012 | CN102716496A Clathrate compound of scutellarin and alkaline cyclodextrin and preparation method thereof |
10/10/2012 | CN102716495A Multifunctional poly(malic acid) carried drug for targeting treatment of tumors |
10/10/2012 | CN102716494A Nucleic acid medicine loading system for targeted therapy and preparation method of nucleic acid medicine loading system |
10/10/2012 | CN102716491A Clathrate compound of artemisinin series and alkaline cyclodextrin and method for preparing same |
10/10/2012 | CN102716488A Glycyrrhizic acid aureola dimer mediated targeted medication body as well as preparation method and purpose of glycyrrhizic acid aureola dimer mediated targeted medication body |
10/10/2012 | CN102716486A Slowly-releasing anticancer drug composition and application thereof |
10/10/2012 | CN102716472A Tumor vaccine and synthetic method thereof |
10/10/2012 | CN102716465A Pharmaceutical composite for treating tumor and preparation method of pharmaceutical composite |
10/10/2012 | CN102716417A Traditional Chinese medicine preparation for treating gynaecopathia and preparation method of preparation |
10/10/2012 | CN102716414A Anti-tumor medicinal composition containing algal polysaccharide sulfate and preparation method for composition |
10/10/2012 | CN102716382A Traditional Chinese medicine composition for treating lung cancer and preparation method thereof |
10/10/2012 | CN102716373A Prescription for treating oncosis and preparation method thereof |
10/10/2012 | CN102716340A Traditional Chinese medicine used for treating esophageal cancer |
10/10/2012 | CN102716320A Medicinal composition for treating non-small cell lung cancer |
10/10/2012 | CN102716319A Cancer-killing radical mixture |
10/10/2012 | CN102716189A Medicine for treating oral cancer |
10/10/2012 | CN102716184A Chinese medicinal composition and application thereof |
10/10/2012 | CN102716162A Preparation technology and preparation method of panoxadiol saponins |
10/10/2012 | CN102716146A Application of water soluble platinum complex to preparation of tumor prevention and treatment medicines |
10/10/2012 | CN102716145A Application of sugar-containing platinum complex in preparation of medicines for preventing and treating tumor |
10/10/2012 | CN102716144A Application of fluorine-containing water-soluble platinum complex to preparation of tumor prevention and treatment medicines |
10/10/2012 | CN102716137A Preparation method and application of fluorescence nanometer diamond-doxycycline compound |
10/10/2012 | CN102716116A Application of compounds containing o-quinone structure in preparation of anti-tumor medicines |
10/10/2012 | CN102716115A Pharmaceutical composition |
10/10/2012 | CN102716114A Pharmaceutical composition comprising germacron, curzerene and borneol |
10/10/2012 | CN102716113A Pharmaceutical composition comprising curzerene |
10/10/2012 | CN102716112A Pharmaceutical composition capable of resisting HPV (human papillomavirus) infection |